Cytokinetics Inc (CYTK)

Oct 01, 2026

CYTK4910847 Bond Profile: Coupon and Redemption - TradingView

Oct 01, 2026

Sep 30, 2026

Cytokinetics, Incorporated (CYTK) stock price, news, quote and history - uk.finance.yahoo.com

Sep 30, 2026

Sep 30, 2026

Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo in Obstructive Hypertrophic Cardiomyopathy - GuruFocus

Sep 30, 2026

Sep 30, 2026

Cytokinetics launches real-world study of heart drug MYQORZO - Investing.com

Sep 30, 2026

Sep 30, 2026

Cytokinetics Announces Start of ASPEN-HCM Real-World Study of MYQORZO in Symptomatic Obstructive HCM - Quiver Quantitative

Sep 30, 2026

Sep 30, 2026

Cytokinetics Launches Aspen-Hcm A Real-World Study Evaluating Myqorzo® (Aficamten) In Symptomatic Obstructive Hypertrophic Cardiomyopathy - TradingView

Sep 30, 2026

Sep 29, 2026

Equity in earnings of Cytokinetics, Incorporated – HAN:KK3A - TradingView

Sep 29, 2026

Sep 29, 2026

Form 4 Cytokinetics Inc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026

Sep 29, 2026

Cytokinetics CEO Robert Blum sells $490,949 in stock - Investing.com

Sep 29, 2026

Sep 28, 2026

Cytokinetics Insider Sold Shares Worth $490,950, According to a Recent SEC Filing - marketscreener.com

Sep 28, 2026

Sep 28, 2026

At $65.46 a share, Cytokinetics (CYTK) CEO Robert Blum sold 7,500 shares after exercising options. - Stock Titan

Sep 28, 2026

Sep 28, 2026

Weekly Recap: MYQORZO US/Germany uptake and COMET/AMBER program updates - TradingView

Sep 28, 2026

Sep 28, 2026

Cytokinetics (CYTK) Insider Trading Activity 2026 $CYTK - MarketBeat

Sep 28, 2026

Sep 25, 2026

Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

CYTK5615147 Bond Profile: Coupon and Redemption - TradingView

Sep 25, 2026

Sep 24, 2026

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo! Finance Canada

Sep 24, 2026

Sep 24, 2026

Cytokinetics, Incorporated (CYTK) Stock forecasts - Yahoo Finance Singapore

Sep 24, 2026

Sep 24, 2026

Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 24, 2026

Sep 23, 2026

Cytokinetics at bernstein healthcare forum: push beyond first launch By Investing.com - Investing.com South Africa

Sep 23, 2026

Sep 23, 2026

Cytokinetics at bernstein healthcare forum: push beyond first launch - Investing.com

Sep 23, 2026

Sep 23, 2026

Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story? - Yahoo Finance

Sep 23, 2026

Sep 22, 2026

Cytokinetics Inc (CYTK) EVP Research & Development Fady Malik Se - GuruFocus

Sep 22, 2026

Sep 22, 2026

Form 4 Cytokinetics Inc For: 22 September - Investing.com India

Sep 22, 2026

Sep 22, 2026

Form 4 Cytokinetics Inc For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Sep 22, 2026

Cytokinetics EVP Fady Malik sells $239k in company stock - Investing.com

Sep 22, 2026

Sep 22, 2026

Cytokinetics EVP Fady Malik sells $239k in company stock By Investing.com - Investing.com Nigeria

Sep 22, 2026

Sep 21, 2026

Here’s How Much You Would Have Made Owning Cytokinetics Stock In The Last 15 Years - Benzinga

Sep 21, 2026

Sep 20, 2026

Cytokinetics stock steadies after recent data and guidance updates - AD HOC NEWS

Sep 20, 2026

Sep 19, 2026

Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 19, 2026

Sep 17, 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Sep 17, 2026

Sep 17, 2026

Cytokinetics CEO, President & Director Robert Blum Sells 44% Of Holding - simplywall.st

Sep 17, 2026

Sep 16, 2026

Cytokinetics CEO Blum’s trust sells $6.7m in company shares By Investing.com - za.investing.com

Sep 16, 2026

Sep 16, 2026

Cytokinetics director Robert Landry sells $72,130 in shares - Investing.com

Sep 16, 2026

Sep 16, 2026

Cytokinetics CEO Blum’s trust sells $6.7m in company shares - Investing.com

Sep 16, 2026

Sep 15, 2026

Cytokinetics Inc (CYTK) Director Robert Landry Sells 1,000 Shares - GuruFocus

Sep 15, 2026

Sep 15, 2026

Trust tied to Cytokinetics (NASDAQ: CYTK) CEO moves to sell shares - Stock Titan

Sep 15, 2026

Sep 15, 2026

Family trust tied to Cytokinetics (NASDAQ: CYTK) CEO just sold about 98,000 shares - stocktitan.net

Sep 15, 2026

Sep 14, 2026

Cytokinetics at Morgan Stanley conference: launch gains and broader bets - Investing.com

Sep 14, 2026

Sep 14, 2026

Patient advocacy groups have until Oct. 2 to apply for heart disease outreach grants - Stock Titan

Sep 14, 2026

Sep 13, 2026

Cytokinetics, Incorporated rStock Price, RCYTK Price, Live Charts, and Marketcap - Coinbase

Sep 13, 2026

Sep 11, 2026

Cytokinetics director Robert Landry sells $74,660 in shares By Investing.com - Investing.com South Africa

Sep 11, 2026

Sep 11, 2026

Cytokinetics director Robert Landry sells $74,660 in shares - Investing.com

Sep 11, 2026

Sep 11, 2026

Cytokinetics (NASDAQ: CYTK) director plans 2,000-share Rule 144 sale - Stock Titan

Sep 11, 2026

Sep 11, 2026

If You Invested $1000 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today - Benzinga

Sep 11, 2026

Sep 11, 2026

Cantor Fitzgerald reiterates Overweight on Cytokinetics stock By Investing.com - Investing.com Australia

Sep 11, 2026

Sep 10, 2026

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says - marketscreener.com

Sep 10, 2026

Sep 09, 2026

Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com - Investing.com Nigeria

Sep 09, 2026

Sep 09, 2026

Transcript : Cytokinetics, Incorporated Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 03 - marketscreener.com

Sep 09, 2026